The single-dose vial presentation has marketing authorization from the national drugs regulator—Central Drugs Standard ...

While the clinical dementia findings did not reach statistical significance, they were the first to provide a hint that early ...

US pharmaceutical giant Eli Lilly has launched its blockbuster diabetes and weight-loss drug, Mounjaro, in India following ...

Investigators said that the OLE study showed Roche’s gantenerumab dropped the risk of developing Alzheimer's symptoms by 50%.

Scientists have developed a revolutionary AI ‘fingerprint’ technology that can accurately show how cancer cells respond to new drugs, by simply observing changes to their shape. The new technology, ...

Biotech and biopharma companies have battled with a drought of private investment in recent years but could now face government funding cuts.

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, ...

British investment firm SV Health Investors has secured $250 million to go toward the development of first-in-class ...

In April 2024, Barinthus Bio announced topline results from the Phase 1b/2 APOLLO dose-ranging trial (also known as HPV001) ...

A platform trial published in The Lancet Neurology looks at the efficacy of anti-amyloid drugs that could delay the onset of Alzheimer’s disease. Prof Robert Howard, Professor of Old Age Psychiatry, ...

NEWTON, MA, USA I March 19, 2025 I Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that ...

NeuroSense Therapeutics Ltd. (NASDAQ: NRSN)* has announced significant progress toward the early commercialization of PrimeC in Canada. According to a Form 6-K filed with the SEC this morning, Health ...